Pathophysiology and epidemiology of abdominal aortic aneurysms

By I. Nordon, R. Hinchliffe, I. Loftus, M. Thompson. Nature Reviews Cardiology, 2011

793 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/029f48771cfd0fd7701e0f5ce64e579da10ebd2a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. Vandooren
2. P. E. Van den Steen
3. G. Opdenakker
4. Toshiyuki Tsuji
5. Michael J. Boyer
6. Tatsuo Kawai
7. Takehiko Takayanagi
8. T. Obama

Citations in the corpus

• Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade (2013, background): “Abdominal aortic aneurysm (AAA) presents as a permanent dilatation of the abdominal aorta and involves upregulation of proteolytic pathways, loss of the arterial wall ECM, inflammation, oxidative stress and apoptosis (Nordon et al., 2011), especially MMP-9 and MMP-12 have been implicated in AAA.”
• Vascular ADAM17 is required for angiotensin II/β-aminopropionitrile-induced abdominal aortic aneurysm (2017, background): “959 Abdominal aortic aneurysm (AAA) is a significant cause of death in the elderly, whereas effective pharmacological intervention is not yet available.(1) Activation of the renin angiotensin II (AngII) system has been implicated in AAA development in human and animal models of AAA.”